Gene: CYRIB
Official Full Name: CYFIP related Rac1 interactor Bprovided by HGNC
Gene Summary: Enables small GTPase binding activity. Involved in several processes, including cellular response to molecule of bacterial origin; negative regulation of small GTPase mediated signal transduction; and regulation of organelle organization. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO07317 | CYRIB Knockout cell line (HeLa) | Human | CYRIB | 1:3~1:6 | Negative | Online Inquiry |
KO07318 | CYRIB Knockout cell line (HCT 116) | Human | CYRIB | 1:2~1:4 | Negative | Online Inquiry |
KO07319 | CYRIB Knockout cell line (HEK293) | Human | CYRIB | 1:3~1:6 | Negative | Online Inquiry |
KO07320 | CYRIB Knockout cell line (A549) | Human | CYRIB | 1:3~1:4 | Negative | Online Inquiry |
CYRIB Gene Knockout Cell Lines represent a state-of-the-art tool for researchers exploring gene function and regulation. These genetically engineered cell lines are created through the targeted deletion of specific genes, employing CRISPR-Cas9 technology to achieve precise editing. This unique feature allows for the investigation of gene knockout effects on cellular processes, signaling pathways, and overall phenotype, providing a powerful platform for functional genomics studies.
The key functions of CYRIB Gene Knockout Cell Lines lie in their ability to facilitate targeted gene disruption, enabling researchers to observe the consequences of gene deletion in vitro. The CRISPR-Cas9 mechanism operates by introducing double-strand breaks at predetermined genomic locations, which are subsequently repaired inaccurately, leading to gene knockout. This highly specific approach not only enhances the fidelity of the modifications but also minimizes off-target effects, a common concern in genetic engineering.
In terms of scientific importance, these cell lines serve as a vital resource in both research and clinical settings. They are invaluable for elucidating gene function, studying disease mechanisms, and drug discovery processes. Additionally, their application in pre-clinical studies significantly contributes to understanding therapeutic targets and potential biomarkers, thus streamlining the translation of research into clinical practice.
Compared to traditional knockout methods, the CYRIB Gene Knockout Cell Lines offer several unique advantages. They provide enhanced efficiency, greater specificity, and faster turnaround times, allowing researchers to generate knockout models more quickly and reliably. This efficiency is crucial in the fast-paced environment of modern biomedical research, where time and accuracy are paramount.
For researchers and clinicians alike, the CYRIB Gene Knockout Cell Lines represent a transformative advancement in the field of genetic research. Their robustness and ease of use empower users to delve deeply into genetic mechanisms while reducing the time and resources typically required for such studies. With years of expertise in genetic engineering and cell line development, our company is committed to providing cutting-edge biological products designed to accelerate scientific discovery and improve research outcomes.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.